1-17 of 17
Heinz-August Horst, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Monitoring of FLT3 Phosphorylation and FLT3 Ligand Levels in Patients with FLT3 -ITD Mutated Acute Myeloid Leukemia (AML) Treated with Midostaurin within the AMLSG 16-10 Trial of the German-Austrian Study Group

Frauke Theis, Daniela Weber, MSc, Frank G. Rücker, MD, Peter Paschka, MD, Verena I. Gaidzik, MD, Felicitas Thol, MD, Michael Heuser, MD, Walter Fiedler, MD, Gerald Wulf, MD, Michael Lübbert, MD PhD, Helmut R. Salih, MD, Thomas Michael Schroeder, MD PhD, Katharina S. Götze, MD, Hans Jürgen Salwender, MD, Thomas Kindler, MD, Heinz-August Horst, MD, Mark Ringhoffer, MD, Dominik Wolf‎, MD, Jürgen Krauter, MD, Richard F. Schlenk, MD, Lars Bullinger, MD, Arnold Ganser, MD, Hartmut Döhner, MD, Konstanze Döhner, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1501.
https://doi.org/10.1182/blood-2018-99-114588
Published: 2018
Journal Articles

Durable Overall Survival Benefit in Patients ≥ 60 Years with Relapsed or Refractory AML Treated with Vosaroxin/Cytarabine Vs Placebo/Cytarabine: Updated Results from the Valor Trial

Farhad Ravandi, MD, Ellen K. Ritchie, MD, Hamid Sayar, MD, Jeffrey E. Lancet, MD, Michael Craig, MD, Norbert Vey, MD PhD, Stephen A. Strickland, Gary J. Schiller, MD, Elias J. Jabbour, MD, Harry P. Erba, MD PhD, Arnaud Pigneux, MD, Heinz-August Horst, MD PhD, Christian Recher, MD PhD, Virginia M. Klimek, MD, Jorge E. Cortes, MD, Gail J. Roboz, Adam R. Craig, MD PhD, Renee Ward, MD PhD, Jennifer Smith, PhD, Hagop M. Kantarjian, MD, Robert K. Stuart, MD
Journal: Blood
Blood (2016) 128 (22): 903.
https://doi.org/10.1182/blood.V128.22.903.903
Published: 2016
Journal Articles

Impact of Age and Midostaurin-Dose on Response and Outcome in Acute Myeloid Leukemia with FLT3 -ITD: Interim-Analyses of the AMLSG 16-10 Trial

Richard F. Schlenk, MD, Walter Fiedler, MD, Helmut R. Salih, MD, Gerald Wulf, MD, Felicitas Thol, MD, Andrea Kündgen, MD, Thomas Kindler, MD, Hans-Juergen Salwender, MD, Michael Lübbert, MD, Peter Brossart, MD, Jörg Westermann, MD Prof, Doris Kraemer, MD, Katharina Goetze, MD, Heinz-August Horst, MD PhD, Jürgen Krauter, MD, Michael Girschikofsky, MD, Mark Ringhoffer, MD, Thomas Südhoff, MD, Gerhard Held, MD, Hartmut H. Kirchner, MD, Wolff Schmiegel, MD, Richard Greil, MD, Martin Griesshammer, MD, Elisabeth Lange, MD, Uwe Martens, MD, Bernd Hertenstein, MD, Maike de Wit, Elisabeth Koller, MD, Andreas L. Petzer, MD, Tanja Hesse, MD, Volker Runde, MD, Peter Reimer, MD, Beate S. Schultheis, MD, Heinz Kirchen, MD, Frank Griesinger, MD, Holger Hebart, MD, Gerhard Heil, Stephan Kremers, David Nachbaur, MD, Nadezda Basara, MD, Carsten Schwänen, Daniel Schöndube, MD, Jochen Greiner, Anja Münnich, Daniela Weber, Verena I. Gaidzik, MD, Maria-Veronica Teleanu, MD, Peter Paschka, MD, Frauke Theis, Axel Benner, Michael Heuser, MD, Konstanze Döhner, MD, Arnold Ganser, MD, Hartmut Döhner, MD
Journal: Blood
Blood (2016) 128 (22): 449.
https://doi.org/10.1182/blood.V128.22.449.449
Published: 2016
Journal Articles

Midostaurin in Combination with Intensive Induction and As Single Agent Maintenance Therapy after Consolidation Therapy with Allogeneic Hematopoietic Stem Cell Transplantation or High-Dose Cytarabine (NCT01477606)

Richard Schlenk, MD, Konstanze Döhner, MD, Helmut Salih, MD, Andrea Kündgen, Walter Fiedler, MD, Hans-Juergen Salwender, MD, Joerg Westermann, MD, Katharina S. Götze, MD, Heinz-August Horst, MD PhD, Gerald Wulf, MD, Michael Lübbert, MD, Doris Kraemer, MD, Thomas Kindler, MD, Mark Ringhoffer, MD, Peter Brossart, MD, Gerhard Held, MD, Richard Greil, Thomas Südhoff, MD, Anja Münnich, Daniela Weber, Verena I. Gaidzik, MD, Maria-Veronica Teleanu, MD, Peter Paschka, MD, Frauke Theis, Michael Heuser, MD, Felicitas Thol, MD, Axel Benner, Arnold Ganser, Hartmut Döhner, Prof. Dr.
Journal: Blood
Blood (2015) 126 (23): 322.
https://doi.org/10.1182/blood.V126.23.322.322
Published: 2015
Journal Articles

Baseline Predictors of Mortality in Patients with Relapsed or Refractory Acute Myeloid Leukemia Treated with Vosaroxin Plus Cytarabine or Placebo Plus Cytarabine in the Phase 3 VALOR Study

Jeffrey E Lancet, MD, Farhad Ravandi, MD, Ellen K Ritchie, MD, Hamid Sayar, MD, Stephen A. Strickland, MD, Gary J Schiller, MD, Norbert Vey, MD, Harry P Erba, MD PhD, Arnaud Pigneux, Heinz-August Horst, MD PhD, Christian Recher, MD, Olatoyosi Odenike, MD, Angelo-Michele Carella, MD, Dominik Selleslag, MD, Jonathan Kell, MD, Utz Krug, MD, Leigh Page, Art DeVault, PhD, Shuling Hwang, MD, Adam R Craig, MD PhD, Robert K. Stuart, MD
Journal: Blood
Blood (2015) 126 (23): 2560.
https://doi.org/10.1182/blood.V126.23.2560.2560
Published: 2015
Journal Articles

Pharmacodynamic Monitoring of the Efficacy of a Targeted Therapy with Midostaurin By Plasma Inhibitor Activity (PIA) Analysis in FLT3 -ITD Positive AML Patients within the AMLSG 16-10 Trial: A Study of the AML Study Group (AMLSG)

Frauke Theis, Peter Paschka, MD, Daniela Weber, Verena I. Gaidzik, MD, Lars Bullinger, MD, Maria-Veronica Teleanu, MD, Gudrun Göhring, MD, Helmut R. Salih, MD, Andrea Kündgen, Hans-Juergen Salwender, MD, Joerg Westermann, MD, Walter Fiedler, MD, Katharina Götze, Heinz-August Horst, MD PhD, Gerald G Wulf, MD, Michael Luebbert, MD, Dominik Wolf, MD, Thomas Kindler, MD, Mark Ringhoffer, MD, Doris Kraemer, MD, Jürgen Krauter, MD, Felicitas Thol, MD, Michael Heuser, MD, Arnold Ganser, MD, Hartmut Döhner, MD, Richard F. Schlenk, MD, Konstanze Döhner, MD
Journal: Blood
Blood (2015) 126 (23): 2585.
https://doi.org/10.1182/blood.V126.23.2585.2585
Published: 2015
Journal Articles

Improved Survival in Patients with First Relapsed or Refractory Acute Myeloid Leukemia (AML) Treated with Vosaroxin Plus Cytarabine Versus Placebo Plus Cytarabine: Results of a Phase 3 Double-Blind Randomized Controlled Multinational Study (VALOR)

Farhad Ravandi, MD, Ellen Ritchie, MD, Hamid Sayar, MD, Jeffrey Lancet, MD, Michael D. Craig, MD, Norbert Vey, MD, Stephen A. Strickland, MD, Gary Schiller, MD, Elias Jabbour, MD, Harry P. Erba, MD PhD, Arnaud Pigneux, MD, Heinz-August Horst, MD, Christian Recher, MD, Virginia M. Klimek, MD, Jorge Cortes, MD, Eric J. Feldman, MD, Adam R. Craig, MD PhD, Judith A. Fox, PhD, Renee Ward, MD PhD, Jennifer Smith, PhD, Gary Acton, MD, Cyrus Mehta, PhD, Hagop M. Kantarjian, MD, Robert K Stuart, MD
Journal: Blood
Blood (2014) 124 (21): LBA-6.
https://doi.org/10.1182/blood.V124.21.LBA-6.LBA-6
Published: 2014
Journal Articles

Impact of Donor Type on Outcome after Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia Patients: Analysis of the German-Austrian Acute Myeloid Leukemia Study Group (AMLSG)

Florian Kuchenbauer, MD PhD, Donald W. Bunjes, MD, Wolfgang Herr, MD, Michael Heuser, MD, Daniela Späth, MSc, Jochen Casper, MD, Heinz-August Horst, MD, Peter Brossart, MD, Gerhard Held, MD, Guido Kobbe, MD, Mark Ringhoffer, MD, Mohammed Wattad, MD, Helmut R Salih, MD, Katharina Götze, Gerald Wulf, MD, Matthias Theobald, MD PhD, Mathias J Rummel, MD, Walter Fiedler, MD, Jörg Westermann, MD PhD, Hans Salwender, MD, Andreas L. Petzer, MD, Frank Hartmann, MD, Michael Lübbert, Uwe Martens, MD, Richard Greil, MD, Hartmut H. Kirchner, MD, Peter Paschka, MD, Verena I. Gaidzik, MD, Veronica Teleanu, MD, Felicitas Thol, MD, Gudrun Göhring, PD, Konstanze Döhner, MD, Arnold Ganser, Hartmut Döhner, MD, Richard F. Schlenk, MD
Journal: Blood
Blood (2014) 124 (21): 1254.
https://doi.org/10.1182/blood.V124.21.1254.1254
Published: 2014
Journal Articles

Prospective Phase III Trial Of Valproic Acid (VPA) In Combination With All-Trans Retinoic Acid (ATRA) and Intensive Induction Therapy For AML In Older Patients: Final and Molecular Subset Analyses Of The AMLSG 06-04 Study

Michela Giulia Tassara, MD, Konstanze Döhner, MD, Peter Brossart, MD, Gerhard Held, Katharina Goetze, MD, Heinz-August Horst, MD, Mark Ringhoffer, MD, Claus-Henning Kohne, MD, Stephan Kremers, MD, Aruna Raghavachar, MD, Gerald Wulf, MD, Heinz Kirchen, MD, David Nachbaur, MD, Hans-Günter Derigs, M.D., Mohammed Wattad, MD, Elisabeth Koller, MD, Wolfram Brugger, MD, Axel C. Matzdorff, MD, PhD, Richard Greil, MD, Gerhard Heil, MD, Daniela Späth, MSc, Peter Paschka, MD, Verena I. Gaidzik, MD, Martin Göttlicher, M.D., Hartmut Döhner, MD, Richard F. Schlenk, MD
Journal: Blood
Blood (2013) 122 (21): 3927.
https://doi.org/10.1182/blood.V122.21.3927.3927
Published: 2013
Journal Articles

Treatment Results In Acute Myeloid Leukemia Over a Time Period Of 20 Years: Analysis Of The German-Austrian Acute Myeloid Leukemia Study Group (AMLSG)

Richard F. Schlenk, MD, Konstanze Döhner, MD, Michael Heuser, MD, Daniela Späth, MSc, Carina Morlok, Alexander Lamparter, Klaus-Henning Koehne, M.D., Heinz-August Horst, MD, Peter Brossart, MD, Gerhard Held, Andrea Kündgen, M.D., Mark Ringhoffer, MD, Mohammed Wattad, MD, Helmut R. Salih, MD, Katharina S. Goetze, MD, Gerald Wulf, MD, Matthias Theobald, MD, PhD, Mathias J. Rummel, MD, Walter Fiedler, MD, Jörg Westermann, MD, Hans Salwender, MD, Andreas L. Petzer, MD, Frank Hartmann, MD, Michael Lübbert, MD, Uwe M. Martens, MD, Richard Greil, MD, Hartmut Kirchner, MD, Peter Paschka, MD, Verena I. Gaidzik, MD, Sabine Kayser, MD, Veronica Teleanu, MD, Felicitas Thol, MD, Gudrun Göhring, MD, Arnold Ganser, MD, Hartmut Döhner, MD
Journal: Blood
Blood (2013) 122 (21): 3878.
https://doi.org/10.1182/blood.V122.21.3878.3878
Published: 2013
Journal Articles

An Adapted Gating Strategy Integrating a Myelomonocytic Window Is Necessary For Correct Flow Cytometric Diagnosis In a Large Proportion Of AML With Mutated NPM1

Miriam Kull, MD, Christian Langer, MD, Michela Tassara, MD, Christine Schoepflin, Olena Bayer, Carina Morlok, Andrea Kündgen, M.D., Helmut R. Salih, MD, Thomas Kindler, MD, Heinz-August Horst, MD, Michael Lübbert, MD, Hans Salwender, MD, Katharina Götze, MD, Felicitas Thol, MD, Arnold Ganser, MD, Peter Paschka, MD, Verena I. Gaidzik, MD, Konstanze Döhner, MD, Hartmut Döhner, MD, Richard F. Schlenk, MD, Michaela Feuring-Buske, MD
Journal: Blood
Blood (2013) 122 (21): 2593.
https://doi.org/10.1182/blood.V122.21.2593.2593
Published: 2013
Journal Articles

Clinical Impact of GATA2 Mutations in Acute Myeloid Leukemia Patients Harboring CEBPA Mutations: A Study of the AML Study Group (AMLSG)

Frauke Theis, Andrea Corbacioglu, PhD, Verena I. Gaidzik, MD, Peter Paschka, MD, Daniela Späth, MSc, Michaela Rehrl, Lars Bullinger, MD, PhD, Brigitte Schlegelberger, MD, PhD, Gudrun Göhring, MD, Claus-Henning Köhne, MD, Ulrich Germing, MD, Peter Brossart, MD, Heinz-August Horst, MD, Detlef Haase, MD, Katharina S. Götze, MD, Mark Ringhoffer, MD, Walter Fiedler, MD, David Nachbaur, MD, Thomas Kindler, MD, Gerhard Held, Michael Lübbert, MD, Mohammed Wattad, MD, Helmut R. Salih, MD, Jürgen Krauter, MD, Michael Heuser, MD, Arnold Ganser, MD, Hartmut Döhner, MD, Richard F. Schlenk, MD, Konstanze Döhner, MD
Journal: Blood
Blood (2013) 122 (21): 1332.
https://doi.org/10.1182/blood.V122.21.1332.1332
Published: 2013
Journal Articles

Impact Of The Pretreatment Characteristics As Well As Cyto- and Molecular-Genetic Profile On Outcome After Relapse In Acute Myeloid Leukemia

Richard F. Schlenk, MD, Peter Frech, Sabine Kayser, MD, Daniela Späth, MSc, Peter Brossart, MD, Heinz-August Horst, MD, Doris M Kraemer, M.D., Gerhard Held, Mark Ringhoffer, MD, Alexander Burchardt, M.D., Andrea Kündgen, M.D., Katharina Goetze, MD, David Nachbaur, MD, Thomas Kindler, MD, Michael Lübbert, MD, Helmut R. Salih, MD, Hans Salwender, MD, Gerald Wulf, MD, Elisabeth Koller, MD, Mohammed Wattad, MD, Walter Fiedler, MD, Stephan Kremers, MD, Heinz Kirchen, MD, Bernd Hertenstein, MD, Peter Paschka, MD, Verena I. Gaidzik, MD, Veronica Teleanu, MD, Michael Heuser, MD, Felicitas Thol, MD, Arnold Ganser, MD, Konstanze Döhner, MD, Hartmut Döhner, MD
Journal: Blood
Blood (2013) 122 (21): 830.
https://doi.org/10.1182/blood.V122.21.830.830
Published: 2013
Journal Articles

Substantially Improved Outcome of Adult Burkitt Non-Hodgkin Lymphoma and Leukemia Patients with Rituximab and a Short-Intensive Chemotherapy; Report of a Large Prospective Multicenter Trial

Dieter Hoelzer, MD, Jan Walewski, Hartmut Döhner, MD, Mathias Schmid, MD, Wolfgang Hiddemann, MD, PhD, Anja Baumann, MD, Hubert Serve, Prof. Dr. med., Ulrich Dührsen, Andreas Hüttmann, Eckhard Thiel, Jolanta Dengler, MD, Michael Kneba, MD, Markus Schuler, MD, Ingo Schmidt-Wolf, MD, Joachim Beck, MD, Bernd Hertenstein, Albrecht Reichle, Katarzyna Domanska-Czyz, Rainer Fietkau, MD, Heinz-August Horst, MD, Harald Rieder, MD, Stefan Schwartz, MD, Thomas Burmeister, MD, Nicola Goekbuget, MD
Journal: Blood
Blood (2012) 120 (21): 667.
https://doi.org/10.1182/blood.V120.21.667.667
Published: 2012
Journal Articles

Long Term Follow-up of 121 Elderly Patients with Philadelphia-Positive Acute Lymphoblastic Leukaemia (Ph+ALL) Treated in Prospective GMALL Trials Supports a Greater Emphasis On Allogeneic SCT as Definitive Postremission Therapy.

Heike Pfeifer, MD, Christoph Wettner, Barbara Wassmann, Aristoteles A.N. Giagounidis, Matthias Stelljes, MD, Ulrich Duehrsen, MD, Marc Schmalzing, MD, Markus Schaich, MD, Maike De Wit, Arnold Ganser, Winfried Gassmann, MD, PhD, Michael Pfreundschuh, MD, Nicolai Haertel, Knut Wendelin, MD, Mathias Schmid, MD, Hans Joachim Beck, Jolanta Dengler, MD, Heinz-August Horst, MD, Michael Lübbert, MD, Hubert Serve, Prof. Dr. med., Nicola Goekbuget, MD, Dieter Hoelzer, MD, Oliver G. Ottmann, MD
Journal: Blood
Blood (2012) 120 (21): 2608.
https://doi.org/10.1182/blood.V120.21.2608.2608
Published: 2012
Journal Articles

CD19/CD3 Bispecific Antibody Blinatumomab (MT-103) Is Highly Effective In Treatment of Patients with Minimal Residual Disease From Chemotherapy-Resistant B-Precursor Acute Lymphoblastic Leukemia

Max S Topp, Gerhard Zugmaier, MD, Nicola Goekbuget, MD, Svenja Neumann, MD, Heinz-August Horst, MD, Thorsten Raff, MD, Monika Brueggemann, MD, Michael Kneba, MD, Andreas Viardot, MD, Mathias Schmid, MD, Markus Schaich, MD, Matthias Stelljes, MD, Mariele Goebeler, MD, Heike Pfeiffer, MD, Oliver Ottmann, MD, Thomas Burmeister, MD, Evelyn Degenhard, Margit Schmidt, PhD, Jürgen Scheele, MD, PhD, Hermann Einsele, MD, Peter Kufer, MD, Matthias Klinger, PhD, Dirk Nagorsen, MD, Dieter Hoelzer, MD, Ralf Bargou, MD
Journal: Blood
Blood (2010) 116 (21): 174.
https://doi.org/10.1182/blood.V116.21.174.174
Published: 2010
Journal Articles

Sensitivity and Applicability of Six-Color Flow Cytometry Is Comparable to ASO-Primer-Real-Time PCR (RQ-PCR) for Minimal Residual Disease (MRD) Monitoring in Adult Acute Lymphoblastic Leukemia (ALL) - A Comparative Analysis in 70 Patients from the German Multicenter Study Group for Adult Acute Lymphoblastic Leukemia (GMALL).

Sebastian Boettcher, MD, Sebastian Irmer, MD, Silke Lueschen, PhD, Matthias Ritgen, MD, Thorsten Raff, MD, Nicola Goekbuget, MD, Dieter Hoelzer, MD, Heinz-August Horst, MD, Michael Kneba, MD, PhD, Monika Brueggemann, MD
Journal: Blood
Blood (2006) 108 (11): 2287.
https://doi.org/10.1182/blood.V108.11.2287.2287
Published: 2006